Austria
| Legal status | VERY RESTRICTIVE |
|---|---|
| Key organization | Forum of Austria Ethics Committees |
| Policy | There is no legislation on stem cell research. Generation of hESC is prohibited and De facto, import or research with hESC is prohibited. The use of human embryos and gametes for research is banned. Procurement of hESCs and therapeutic and reproductive cloning are prohibited. |
| Legislation | The ACT on reproductive medicine (FORTPFLANZUNGSMEDIZINGESETZ of June 1992)The ACT on human embryo researchis the Reproductive Medicine ACT amendment 2004 (FORTPFLANZUNGSMEDIZINGESETZ geändert wird FORTPFLANZUNGSMEDIZINGESETZ -Novelle 2004) |
| Legislation Link | Fortpflanzungsmedizingesetz am 4 juni 1992, Reproductive Medicine Act of 4 June 1992, at http://www.ris.bka.gv.at/Dokumente/BgblPdf/1992_275_0/1992_275_0.pdfFortpflanzungsmedizingesetz geändert wird (Fortpflanzungsmedizingesetz-Novelle 2004 – FMedGNov 2004), Reproductive Medicine Act Amendment 2004 – FmedGNov 2004, at http://www.ris.bka.gv.at/Dokument.wxe?Abfrage=BgblAuth&Dokumentnummer=BGBLA_2004_I_163, |
| Embryonic stem cell research policy | No specific legislation on hESC research.Generation of hESC is prohibited and De facto, import or research with hESC is prohibited. However, the Austrian Bioethics Commission advocates hESC derivation from surplus embryos (majority position with dissenting opinion). |
| Research with embryo | Bans the use of human embryos for research purpose |
| Embryo donation and cryopreservation | Gametes donation is forbidden, other than medically assisted reproduction in the frame of heterosexual relationshipsProhibited to use human embryos for any other purpose than assisted reproduction. |
| Somatic cell nuclear transfer | Prohibited therapeutic and reproductive cloning |
| Privacy and data protection | Federal Act Concerning the Protection of Personal Data (2009): http://www.ris.bka.gv.at/Dokument.wxe?Abfrage=Erv&Dokumentnummer=ERV_1999_1_165 |
| Funding | Regarding public funding for research, adult stem cells are prioritised over hESCs. |
Projects
- A stem cell-based approach for modelling in vitro implantation
- Cerebral organoids: human mini brains in a dish open up new possibilities for drug development in neurodegenerative and developmental diseases
- Cerebral Organoids: Using stem cell derived 3D cultures to understand human brain development and neurological disorders
- Coupling morphogen dynamics with mechanics in the control of form and pattern
- Developmentally programmed pediatric sarcomas: a versatile platform for drug discovery and molecular precision medicine
- Disease modelling of frontotemporal dementia (FTD) in cerebral organoids
- hiPSC for Relapse Prevention in Chronic Autoimmunity
- Human blastoids: A discovery platform for early human embryogenesis
- Human blastoids: A drug discovery platform for women’s reproductive health
- Induced pluripotent stem cell lines (iPSC lines) produced from skin and blood cells.
- Investigating impact of schizophrenia associated non-coding variants using brain organoids
- Investigating the regenerative and proliferative competencies of human retinal pigment epithelial cells
- Mechanochemical feedbacks between physical forces and morphogen signaling during hESC self-organization
- Microglia action towards neuronal circuit formation and function in health and disease
- Pheno-connectomics of human neurodevelopmental diseases
- Role of neural stem cell behavior in neocortical expansion across species
- Swept lasers for non-invasive diagnostics
- Toward an understanding of the brain interstitial system and the extracellular proteome in health and autism spectrum disorders
- Understanding the role of transposable elements in establishing gene regulatory networks during early embryonic lineage commitment and segregation
Provider
- Angios GmbH
- IMP - Research Institute of Molecular Pathology
- Innsbruck Medical University
- Innsbruck Medical University - Department of Neurology
- Institute of Molecular Biotechnology
- Institute of Science and Technology Austria
- Medical University of Graz
- Medical University of Graz - Department for Blood Group Serology and Transfusion Medicine
- Medical University of Vienna
- Paracelsus Medical University
- Paracelsus Medical University - Institute of Experimental and Clinical Cell Therapy
- St. Anna Kinderkrebsforschung GmbH
- University of Innsbruck, Institute of Molecular Biology
hESC Cell lines
hiPSC Cell lines
- TMOi001-A-1
- IBKMOLi001-A
- IBKMOLi002-A
- PMUi001-A
- PMUi001-B
- PMUi001-C
- PMUi001-D
- PMUi002-A
- PMUi002-B
- PMUi002-C
- PMUi002-A-1
- PMUi002-A-2
- PMUi002-A-3
- UBTi001-A
- IMBAi001-A
- IMBAi002-A
- IMBAi003-A
- IMBAi001-B
- IMBAi002-B
- IMBAi002-C
- IMBAi003-B
- IMBAi004-A
- IMBAi004-B
- IMBAi004-C
- IMBAi005-A
- IMBAi005-B
- IMBAi005-C
- IMBAi006-A
- IMBAi006-B
- IMBAi006-C
- IMBAi007-A
- IMBAi007-B
- IMBAi007-C
- IMBAi008-A
- IMBAi008-B
- IMBAi008-C
- IBKMOLi003-A
- IBKMOLi004-A
- IBKMOLi005-A
- IMBAi009-A
- IMBAi009-B
- IMBAi009-C
- IMBAi010-A
- IMBAi010-B
- IMBAi010-C
- IMBAi011-A
- IMBAi011-B
- IMBAi012-A
- IMBAi013-A
- IMBAi014-A
- IMBAi015-A
- IMBAi016-A
- IMBAi017-A
- IMBAi018-A
- IMBAi019-A
- IMBAi020-A
- IMBAi020-B
- RUCDRi002-A-72
- UBTi002-A
- UBTi002-B
- UBTi002-C
- IMBAi001-A-1
- IMBAi017-A-1
- IMBAi017-A-2
- IMBAi011-C
- IBKMOLi006-A
- IBKMOLi007-A